- Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort2018 | First Faculty of Medicine
- Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response2010 | Faculty of Medicine in Pilsen
- Průběžná analýza FÁZE 2B (týden 12) výsledků léčby albumin interferonem alfa-2B v kombinaci s ribavirinem u chornické infekce virem hepatitidy C genotypu 1Publication without faculty affiliation
- USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study2015 | First Faculty of Medicine, Central Library of Charles University
- Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection2015 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C2014 | First Faculty of Medicine
- Report of University Hospital Hradec Králové to the clinical trial protocol No. AI452-020-0030Publication without faculty affiliation
- Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis2015 | First Faculty of Medicine
- Viral proteases as therapeutic targets2022 | Central Library of Charles University, Faculty of Science
- Distribution of varicella-zoster virus (VZV) wild-type genotypes in northern and southern Europe: evidence for high conservation of circulating genotypes2009 | Publication without faculty affiliation
- A comparison of cost-effectiveness analysis of two strategies - immediate and delayed initiation of treatment of hepatitis C in the Czech Republic2018 | First Faculty of Medicine
- Ancient human parvovirus B19 in Eurasia reveals its long-term association with humans2018 | First Faculty of Medicine
- A high prevalence of viral hepatitis C in a socially excluded Roma community in Brno2019 | First Faculty of Medicine
- Efficacy and safety of peginterferon alpha-2a (40KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe2011 | First Faculty of Medicine
- Effect of antiviral treatment of chronic hepatitis C on the frequency of regulatory T cells, T-cell activation, and serum levels of TGF-beta2016 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy and safety of elbasvir/grazoprevir and sofosbuvir/pegylated interferon/ribavirin: A phase III randomized controlled trial2016 | First Faculty of Medicine
- Genome-wide association study to characterize serum bilirubin elevations in patients with HCV treated with GS-9256, an HCV NS3 serine protease inhibitor2014 | First Faculty of Medicine
- Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis2017 | First Faculty of Medicine